Workshop on Better Health through Bio-medicine: Innovative Governance

For many of today’s new biomedical innovations, the distinctions between different forms of medical products such as drugs, diagnostics and devices no longer apply. Biomedicine also tends to realize its potential today through process innovation, even more than product innovation.

Related Documents

• Task Force on Biomedicine and Health Innovation

Summary of the Discussion Panel on the Development of Strategies for Measuring and Reporting Sustainability of Bio-based Energy and Products

This report is on how to support governments and industry in building a sustainable bio-based economy. The OECD Task Force on Industrial Biotechnology is considering the development of a set of recommendations in the area of Environmental and Economic Sustainability.

Discussion Panel on the Development of Strategies for Measuring and Reporting Sustainability of Bio-based Energy and Products

The main objectives of the panel were to launch the report from Montreal Workshop entitled “Towards the Development of OECD Best Practices for Assessing the Sustainability of Bio-based Products” and to communicate its main conclusions.

Industrial and Environmental Biotechnology

The key goal of the current work is to identify further means (e.g. international guidelines, policy recommendations) to implement the 2004 OECD Science and Technology Ministers mandate on “Biotechnology for Sustainable Growth and Development” .

International Symposium on Opportunities and Challenges in the Emerging Field of Synthetic Biology: Synthesis Report

This July 2009 symposium brought together the different communities – scientific, engineering, policy, public and legal – involved in synthetic biology and explored the opportunities and challenges posed by this emerging field.

Related Documents

• International Symposium on Opportunities and Challenges in the Emerging Field of Synthetic Biology - 9-10 July 2009

OECD Workshop on Outlook on Industrial Biotechnology

Workshop discussions were structured around a set of issues papers – one for each of the sessions. The workshop was set up as a working roundtable discussion. 50 participants familiar with data sources for industrial biotechnology attended the workshop.

Guidelines for a Harmonised Statistical Approach to Biotechnology Research and Development in the Government and Higher Education Sectors

The aim of these guidelines is to propose a harmonised approach for the collection and analysis of biotechnology research and development (R&D) statistics in the government and higher education sectors.

Pharmacogenetics: Opportunities and Challenges for Health Innovation

This book reviews how the emergence of pharmacogenetics will impact the efficiency of pharmaceutical R&D and improve healthcare decision making and clinical care. It discusses what policies need to change in order for the public to reap the benefits from advances in diagnostic genetic testin

Related Documents

• Workshop on Pharmacogenetics: The Intersections between Innovation, Regulation and Health Delivery
• Genetics and Genomics
• Innovation in Pharmaceutical Biotechnology: Comparing National Innovation Systems at the Sectoral Level
• The OECD Innovation Strategy

Guidelines for Human Biobanks and Genetic Research Databases (HBGRDs)

The ability to effectively use these vast amounts of knowledge will depend in part on the bringing together of different strands of information, data and biological materials within human biobanks and genetic research databases (HBGRDs).

Related Documents

• Creation and Governance of Human Genetic Research Databases
• Genetics and Genomics

OECD Workshop on Best Practices in Assessing the Environmental and Economic Sustainability of Bio-based Products - Agenda and Presentations

The workshop discussed existing sector, national, or international approaches for assessment of sustainability of bio-based products, such as bio-based chemicals, bio-based plastics, enzymes, bio-based materials, and biofuels.